Results 11 to 20 of about 169,175 (266)

Aggressive lipid-lowering therapy before and after revascularization in patients with stable coronary artery disease

Медицинский совет, 2013
The review presents data on the effectiveness of lipid profile correction with maximum doses of statins, primarily atorvastatin, and lipoprotein apheresis.
R. N. Adzhiev, M. S. Safarova, M. V. Yezhov, Y. G. Matchin   +3 more
doaj   +1 more source

Evaluation of the correlation between end-tidal arterial carbon dioxide pressure based on mainstream capnography technique and arterial carbon dioxide pressure based on arterial blood gas analysis before and after cardiopulmonary bypass pump in children with non-cyanotic congenital heart defects [PDF]

مجله پزشکی دانشگاه علوم پزشکی تبریز, 2022
Background. It is still a matter of debate whether the evaluation of end-tidal carbon dioxide (ETCO2) using a capnography device allows the evaluation of non-invasive monitoring of arterial carbon dioxide pressure (PaCO2).
Ashkan Taghizadeh, Hooman Naghashian, Rojin Faroughi, Behrang Nooralishahi   +3 more
doaj   +1 more source

N-3 polyunsaturated fatty acids reduces post-operative atrial fibrillation incidence in patients undergoing “on-pump” coronary artery bypass graft surgery

Monaldi Archives for Chest Disease, 2015
Background: The aim of this study was to evaluate the efficacy of preoperative and postoperative therapy with n-3 polyunsaturated fatty acids in reducing the incidence of atrial fibrillation after coronary artery bypass graft surgery.
Mario Sorice, Francesco Paolo Tritto, Chiara Sordelli, Rosario Gregorio, Luigi Piazza   +4 more
doaj   +1 more source

Characteristics of early pleural effusions after orthotopic heart transplantation: comparison with coronary artery bypass graft surgery

Monaldi Archives for Chest Disease, 2021
Pleural effusions appearing within the first 30 postoperative days following coronary artery bypass grafting are classified as early and believed to be directly related to cardiac surgery.
Anant Jain, Anusha Devarajan, Hussein Assallum, Ramin Malekan, Gregg Lanier, Oleg Epelbaum   +5 more
doaj   +1 more source

A modified technique for reducing the duration of ischemic time of the heart and myocardial reperfusion in multivalve correction combined with coronary grafting

Кардіохірургія та інтервенційна кардіологія, 2023
The aim – to develop and put into practice a method of reducing the ischemic time of the heart during long-term cardiac surgery interventions. Materials and methods. A modified technique of coronary artery bypass grafting has been developed for combined
P.M. Semeniv
doaj   +1 more source

The results of staged endovascular revascularization with use of stents with third generations of drug-eluting and biodegradable polymer in patients with acute coronary syndrome and multivessel coronary artery disease

Клиническая практика, 2019
Background. Acute coronary syndrome (ACS) is currently the leading cause of peoples death worldwide. Objective. Based on the analysis of a combined end point, MACCE, to estimate the efficacy and safety of the strategy of staged endovascular ...
Aleksandr V. Bocharov, Leonid V. Popov
doaj   +1 more source

Ways to improve the results of surgical treatment of patients with multiple valve correction in combination with coronary pathology

Український журнал серцево-судинної хірургії, 2019
Aim of the study. To determine the effect of surgical tactics on the duration of ischemic period with simultaneous combined correction of two or three valves of the heart and myocardial revascularization Materials and methods. The work is based on the
R. M. Vitovsky, P. M. Semeniv, O. V. Kupchynskyi, V. F. Onishchenko, L. A. Klymenko   +4 more
doaj   +1 more source

Surgical treatment of obesity and excess risk of developing heart failure in a controlled cohort study

ESC Heart Failure, 2022
Aim We aim to assess the risk of heart failure in patients with obesity with and without gastric bypass surgery compared with population controls. Methods and results This cohort study included all patients aged 20–65 years with a first ever registered ...
Christina E. Lundberg, Shabbar Jamaly, Martin Adiels, Jesper Lagergren, Carl Johan Svensson, Lena Björck, Annika Rosengren   +6 more
doaj   +1 more source

Thoracic Duct Lymphovenous Bypass: A Preliminary Case Series, Surgical Techniques, and Expected Physiologic Outcomes

Plastic and Reconstructive Surgery, Global Open, 2022
Background:. In patients with recalcitrant mechanical thoracic duct obstruction, microsurgical lymphovenous bypass is an emerging therapeutic option.
Yoshiko Toyoda, MD, Cody Fowler, MD, Daniel M. Mazzaferro, MD, MBA, J. Reed McGraw, BS, Sammy Othman, MD, Said C. Azoury, MD, Maxim Itkin, MD, Stephen J. Kovach III, MD   +7 more
doaj   +1 more source

Efficacy and safety of haemostatic agents for patients receiving antiplatelet therapy before coronary artery bypass grafting: a protocol for a systematic review and network meta-analysis of randomised controlled trials

BMJ Open
Introduction Most patients undergoing coronary artery bypass grafting (CABG) receive preoperative antiplatelet therapy to reduce ischaemic events but this increases perioperative bleeding and transfusion risk.
Chao Chen, Ying Xiong, Xiao Ren, Yunfei Han, Xinguang Wei, Qiubei Xiao, Ruirui Mao   +6 more
doaj   +1 more source